mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.45 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |